Governance Valneva

VLA

FR0004056851

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 16:55:00 06/02/2026 GMT			5-day change	1st Jan Change
4.028 ^EUR	-1.27%		+3.60%	+8.34%

02-03	Global markets live: SpaceX, Tesla, Boeing, PayPal, AstraZeneca…
02-03	Valneva, Instituto Butantan Start Pilot Program for Chikungunya Vaccine in Brazil	MT

Executive Committee: Valneva

Manager

Positions heldSince

Thomas Lingelbach

62 year

Chief Executive Officer	-
President	09/05/2013

Juan Carlos Jaramillo

55 year

Chief Tech/Sci/R&D Officer

30/09/2020

Vincent Dequenne

59 year

Chief Operating Officer

31/12/2023

Joshua Drumm

Investor Relations Contact

30/06/2021

Peter Buhler

56 year

Director of Finance/CFO

28/07/2021

Composition of the Board of Directors: Valneva

Director

CommitteesSince

Anne-Marie Graffin

64 year

Compensation Committee Chair	06/04/2015
Nominating Committee Chair	06/04/2015
Audit Committee	31/12/2021
Compensation Committee	31/12/2021

James Sulat

75 year

Compensation Committee	06/03/2013
Nominating Committee
Audit Committee Chair	06/03/2013
Governance Committee Chair	06/03/2013

Gerd Zettlmeissl

70 year

Audit Committee	21/05/2019
Compensation Committee	21/05/2019
Nominating Committee	21/05/2019

Danièle Guyot-Caparros

66 year

Audit Committee	02/10/2022
Compensation Committee	31/12/2023
Audit Committee Chair	08/10/2025

Jim Connolly

61 year

Audit Committee	23/06/2022
Governance Committee	23/06/2022

Maïlys Ferrère

62 year

Governance Committee
Audit Committee

Kathrin Jansen

67 year

Director/Board Member

20/06/2023

Thomas Lingelbach

62 year

Director/Board Member

19/12/2023

Latest Appointments: Valneva

14/07/25	French and Benelux stocks-Factors to watch	RE
25/06/25	Valneva SE Appoints Gerd Zettlmeissl to the Board	CI
04/06/25	Franck Grimaud to Leave as Chief Business Officer of Valneva SE on June 25, 2025	CI
26/06/24	Valneva SE Appoints Daniele Guyot-Caparros as Board of Directors	CI
21/05/24	Valneva Se Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer	CI
21/05/24	Valneva Names New Chief Scientific Officer	MT
21/05/24	Valneva appoints Scientific Director

More news

Former Officers and Directors: Valneva

Insider

Positions held

SinceUntil

Franck Grimaud

Corporate Officer/Principal	09/05/2013	24/06/2025
President	-	-

Frédéric Jacotot

General Counsel	31/03/2017	30/07/2024
Corporate Secretary	31/03/2017	30/07/2024

Frédéric Grimaud

Chairman

11/12/2012

19/12/2023

Johanna Willemina Pattenier

Director/Board Member	16/06/2020	19/12/2023
Independent Dir/Board Member	16/06/2020	19/12/2023

Sharon Tetlow

Director/Board Member	16/06/2020	19/12/2023
Independent Dir/Board Member	16/06/2020	19/12/2023

Klaus Schwamborn

Corporate Officer/Principal

28/02/2013

30/06/2022

Thomas Casdagli

Director/Board Member

11/12/2019

11/03/2021

Perry Denis Celentano

Chief Operating Officer

10/01/2021

Wolfgang Bender

Chief Tech/Sci/R&D Officer

31/08/2017

30/09/2020

Sandra E. Poole

Director/Board Member	29/06/2017	16/06/2020
Independent Dir/Board Member	29/06/2017	16/06/2020

Louisa Shaw-Marotto

Director/Board Member

29/06/2016

16/06/2020

Alexander Ullrich von Gabain

Director/Board Member	06/03/2013	16/06/2020
Independent Dir/Board Member	06/03/2013	16/06/2020

Bali Muralidhar

Director/Board Member

30/04/2017

11/12/2019

Ralf Clemens

Director/Board Member	29/06/2016	31/12/2018
Independent Dir/Board Member	29/06/2016	31/12/2018

David Lawrence

Director of Finance/CFO

06/08/2017

Reinhard Kandera

Director of Finance/CFO

09/05/2013

Frédéric Legros

Corporate Officer/Principal

31/12/2016

Hans Lennart Rudolf Wigzell

Director/Board Member	06/03/2013	29/06/2016
Independent Dir/Board Member	06/03/2013	29/06/2016

Michel Gréco

Director/Board Member	11/12/2012	29/06/2016
Independent Dir/Board Member	11/12/2012	29/06/2016

Manfred Tiefenbacher

Corporate Officer/Principal

31/10/2015

Majid Mehtali

Chief Tech/Sci/R&D Officer

31/07/2013

Anne-Sophie Herelle

Director/Board Member

30/06/2013

Matthias Hebben

Corporate Officer/Principal

31/05/2008

31/12/2012

Alain Munoz

Director/Board Member	11/12/2012	-
Independent Dir/Board Member	11/12/2012	-

Olivier Jankowitsch

Corporate Officer/Principal

31/10/2006

Jason Golan

Corporate Officer/Principal	-	-
Sales & Marketing	28/02/2006	-

Bruno Bézard

Director/Board Member

Andreas Meinke

Chief Tech/Sci/R&D Officer

Gerald Strohmaier

Human Resources Officer

Michael Möhlen

Chief Tech/Sci/R&D Officer

Kerstin Westritschnig

Chief Tech/Sci/R&D Officer

Mogens Vang Rasmussen

Corporate Officer/Principal

Samuel Dalens

Director/Board Member

Age distribution of managers

Parity Men Women

Male	9
Female	5

Of which Executive Committee

Male	5
Female	0

Of which Directors

Male	5
Female	3

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. Valneva takes a highly specialized and targeted approach, applying its deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. Valneva has a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines. Revenues from its growing commercial business help fuel the continued advancement of Valneva's vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development, which is partnered with Pfizer, the world's most clinically advanced tetravalent Shigella vaccine candidate as well as vaccine candidates against the Zika virus and other global public health threats.

Employees

713

Sector

Biotechnology & Medical Research

Calendar

03-18 - Q4 2025 Earnings Release (Projected)

More about the company